| Literature DB >> 34922339 |
Qian Zeng1, Fangfang Jin1, Husun Qian1, Hongling Chen1, Yange Wang1, Dian Zhang1, Yu Wei1, Tingmei Chen1, Bianqin Guo2, Chengsen Chai1.
Abstract
Breast cancer is the most common malignancy among women worldwide. Functional studies have demonstrated that miRNA dysregulation in many cases of cancer, in which miRNAs act as either oncogenes or tumor suppressor. Here we report that miR-345-3p is generally upregulated in breast cancer tissues and breast cancer cell lines. Overexpression and inhibition of miR-345-3p revealed its capacity in regulating proliferation and invasion of breast cancer cells. Further research identified protein phosphatase 2 catalytic subunit alpha (PPP2CA), a suppressor of AKT phosphorylation, as a candidate target of miR-345-3p. In vitro, miR-345-3p mimics promoted AKT phosphorylation by targeting its negative regulator, PPP2CA. Blocking miR-345-3p relieved its inhibition of PPP2CA, which attenuated PI3K-AKT signaling pathway. In vivo, inhibiting miR-345-3p by miR-345-3p-inhibition lentivirus suppressed tumor growth and invasiveness in mice. Together, the miR-345-3p/PPP2CA signaling axis exhibits tumor-promoting functions by regulating proliferation and invasion of breast cancer cells. These data provide a clue to novel therapeutic approaches for breast cancer.Entities:
Mesh:
Substances:
Year: 2022 PMID: 34922339 PMCID: PMC9272193 DOI: 10.1093/carcin/bgab124
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.741